Prof. Kui Liu | Breast Cancer | Best Researcher Award

Posted on by Pencis

Prof. Kui Liu | Breast Cancer | Best Researcher Award

Zibo Central Hospital | China

AUTHOR PROFILE

Scopus

KUI LIU, Ph.D. – PROFESSIONAL PROFILE

🎓 EARLY ACADEMIC PURSUITS

Kui Liu embarked on a robust academic journey in clinical and diagnostic sciences:

  • 2002-2005: Completed a degree in Clinical Laboratory Medicine from Linyi Medical College, China.
  • 2012-2015: Pursued a master’s degree in Clinical Laboratory Diagnostics at Jiangsu University, Zhenjiang, China.
  • 2016-2020: Earned a Ph.D. in Immunology from Southeast University, Nanjing, China, contributing significantly to the field with innovative research in immune responses and diagnostics.

💼 PROFESSIONAL ENDEAVORS

Kui Liu has accumulated extensive clinical and technical experience over nearly two decades:

  • 2020-Present: Associate Chief Technician at the Center of Translational Medicine, Zibo Central Hospital, where he plays a key role in integrating research with clinical applications.
  • 2015-2016: Worked as a Docimaster at the Blood Bank of the First Hospital of Zibo, focusing on blood storage and safety protocols.
  • 2008-2012: Served as a Docimaster at the same institution, ensuring high-quality diagnostic practices.
  • 2005-2008: Began his career as a Docimaster in the Laboratory Department, excelling in clinical diagnostics.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER

Kui Liu’s research is centered on advancing the fields of immunology and clinical diagnostics, with a focus on:

  • The study of immune responses in various pathological conditions.
  • Development of innovative diagnostic tools and techniques.
  • Translation of scientific research into clinical solutions.

His work on immune mechanisms and diagnostic technologies has led to groundbreaking advancements in translational medicine.

💡 FUNDING AND RESEARCH IMPACT

Kui Liu has been a driving force behind several high-impact research projects, securing prestigious grants to fund cutting-edge studies:

  • Grant no. 81602330: Principal Investigator for the National Natural Science Foundation of China (2017-2019), focusing on immunological research.
  • Grant no. 81972002: Co-Investigator for the National Natural Science Foundation of China (2019-2022), contributing to collaborative advancements in the field.
  • Grant no. J18KA299: Co-Investigator in the Shandong Province Higher Educational Science and Technology Program (2019-2021).
  • Grant no. ZR2015PH056: Co-Investigator for the Natural Science Foundation of Shandong Province (2015-2016).
  • Grant no. CXLX13_689: Principal Investigator for the Innovation Project of Cultivating Graduates of Jiangsu Province (2013-2015).

🌍 IMPACT AND INFLUENCE

  • Innovator in Translational Medicine: Kui Liu has bridged the gap between laboratory research and clinical application, enhancing diagnostic capabilities in immunology.
  • National and Regional Contributions: Through leadership in provincial and national projects, he has elevated the standards of diagnostic medicine across China.
  • Collaboration and Mentorship: Actively fosters collaborations and guides aspiring researchers, contributing to the growth of the next generation of medical scientists.

📚 ACADEMIC CITES AND RECOGNITION

Kui Liu has received widespread recognition for his contributions, reflected in numerous citations and acknowledgments in scientific journals. His findings have influenced medical practices and inspired continued exploration in immunology.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kui Liu’s career is a testament to his commitment to advancing medical science. His future endeavors include:

  • Leading innovative studies in immunological diagnostics.
  • Expanding the applications of translational medicine.
  • Continuing to inspire young researchers through mentorship and collaboration.

🌟CONCLUSION 

Dr. Kui Liu’s remarkable journey from foundational clinical studies to advanced immunological research exemplifies a career dedicated to innovation, excellence, and impact. His contributions to translational medicine and diagnostics have not only advanced scientific understanding but also improved clinical practices, particularly in immunology.

 

📊🔬NOTABLE PUBLICATION:
    1. Title: LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells
      • Authors: Zhang, X.H., Li, B.F., Ding, J., Ma, F.X., Wu, X.Y.
      • Journal: Cancer Management and Research
      • Year: 2020
    1. Title: LncRNA PVT1 Regulates Gallbladder Cancer Progression through miR-30d-5p
      • Authors: Liu, K., Xu, Q.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020
    1. Title: TIPE1 Inhibits Osteosarcoma Tumorigenesis and Progression by Regulating PRMT1 Mediated STAT3 Arginine Methylation
      • Authors: Yang, M., Zhang, Y., Liu, G., Liu, Q., Zhao, P.
      • Journal: Cell Death and Disease
      • Year: 2022
    1. Title: CircRNA hsa_circ_0008500 Acts as a miR-1301-3p Sponge to Promote Osteoblast Mineralization by Upregulating PADI4
      • Authors: Zhai, Q., Zhao, Y., Wang, L., Li, T., Wang, L.
      • Journal: Frontiers in Cell and Developmental Biology
      • Year: 2020
    1. Title: miR-369-3p Inhibits Tumorigenesis of Hepatocellular Carcinoma by Binding to PAX6
      • Authors: Xu, Q., Liu, K.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Posted on by Pencis

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Hunan provincial people’s hospital | China

AUTHOR PROFILE

Scopus

🌟Wu Yaqin 

🏥CURRENT ROLES AND AFFILIATIONS 

  • Current Position: Organizational Committee Member, Graduate Student Party Branch
  • Graduate Institution: Hunan Provincial People’s Hospital (Hunan Normal University First Affiliated Hospital), Breast and Thyroid Surgery, Master’s Supervisor: Professor Zhang Chaojie
  • Undergraduate Institution: Hunan Normal University Medical School, Clinical Medicine (2014.9–2019.6)

📚EARLY ACADEMIC PURSUITS 

Wu Yaqin began her academic journey at Hunan Normal University Medical School, excelling in Clinical Medicine. Her undergraduate years were marked by stellar academic performance, with scholarships awarded every year, including National Scholarship and National Inspirational Scholarship.

🔬PROFESSIONAL ENDEAVORS 

Currently pursuing a Master’s degree in Surgery (Breast and Thyroid Surgery) at Hunan Provincial People’s Hospital, Wu has honed her clinical and research skills. She has gained recognition for:

  1. Outstanding clinical rotation performance.
  2. Active participation in surgeries, assisting in level 3 and 4 operations.
  3. Representing her hospital in Clinical Skills Competitions.

🧪CONTRIBUTIONS AND RESEARCH FOCUS 

Wu Yaqin has a strong foundation in research and innovation, focusing on:

  • Scientific Techniques: Proficiency in WB, PCR, single-cell sequencing, metabolomics, and other experimental skills.
  • Data Analysis: Skilled in SPSS, bioinformatics, and advanced statistical analysis.
  • Publications:
    • 2 SCI papers as the first and corresponding author (Cumulative Impact Factor: 5.143).
    • 2 core journal publications in China.
  • Research Projects:
    • Contributed to two provincial-level projects and two horizontal projects as the lead researcher (under mentor guidance).

🌟IMPACT AND INFLUENCE 

Wu’s contributions extend beyond academia:

  • Regularly earns recognition as an Outstanding Party Member, Student, and Graduate.
  • Actively involved in expert consensus compilation, adding to professional guidelines.
  • Participates in large-scale event organization with exceptional planning and execution skills.

PERSONAL SKILLS AND INTERESTS 🎙️

  • Language Proficiency:
    • Passed CET-4 and CET-6.
    • Achieved Grade 2-A in the National Mandarin Test.
  • Technical Skills:
    • Proficient in basic and advanced experimental techniques.
    • Skilled in computer applications (provincial-level certification).
  • Special Interests: Broadcasting, hosting, debate, and recitation.

RECOGNITION AND HONORS 🏅

During Master’s Program:

  • Authored high-impact research papers.
  • Contributed to prestigious projects and received multiple awards for academic excellence.

During Undergraduate Program:

  • Awarded numerous scholarships and honors.
  • Served in various leadership roles:
    • Vice Minister, Learning Department of the Student Union.
    • Captain, Debate Team.
    • Psychological Committee Member, Class Representative.

LEGACY AND FUTURE CONTRIBUTIONS 🌐

Wu Yaqin’s dedication to clinical excellence, innovative research, and effective communication positions her as a rising star in medical sciences. She is committed to:

  1. Advancing clinical practice and surgical expertise.
  2. Expanding her impact through cutting-edge research and mentorship roles.
  3. Building a legacy of leadership and service within the medical community.

 

📊🔬NOTABLE PUBLICATION:
  • 1. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    • Authors: Huang, S.-L., Huang, Z.-C., Zhang, C.-J., Wu, Y.-Q., Fan, P.-Z.
    • Journal: Breast Cancer
    • Year: 2022

    2. The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis

    • Authors: Kong, C., Zhang, C., Wu, Y., He, J., Fan, P.
    • Journal: Gland Surgery
    • Year: 2020

    3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

    • Authors: Wang, H., Fang, Q., You, S., Wu, Y., Zhang, C.
    • Journal: Genes and Genomics
    • Year: 2023

    4. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

    • Authors: Xiao, X., Wu, Y., Zou, L., Chen, Y., Zhang, C.
    • Journal: Gland Surgery
    • Year: 2022

    5. A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis

    • Authors: Zhang, C., Wu, Y., Wang, H., Li, Q., Fan, P.
    • Journal: Gland Surgery
    • Year: 2021

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Haruto Nishida | Breast Cancer Immunity | Best Researcher Award

Faculty of Medicine, Oita University | Japan

Author Profile

Scopus

🧬 Dr. Haruto Nishida, M.D., Ph.D. – Associate Professor of Diagnostic Pathology

Haruto Nishida, M.D., Ph.D., is an Associate Professor at the Department of Diagnostic Pathology at Oita University Hospital, Japan, where he has served in this role since April 2021. Dr. Nishida has a profound expertise in pathology, with a particular focus on diagnostic pathology, cytology, and molecular pathology.

🎓 Education and Early Career

Dr. Nishida earned his Medical Degree from the Faculty of Medicine at Oita University in 2009. He furthered his academic journey by obtaining a Ph.D. from the same institution in 2015, specializing in pathology. His post-graduate training includes a residency in General Medicine at Oita Medical Hospital and a fellowship in Diagnostic Pathology at Oita University.

🩺 Professional Experience

Dr. Nishida’s career at Oita University has been marked by progressive roles. Starting as an Assistant Professor in 2012, he was promoted to Lecturer in 2019 and then to Associate Professor in 2020. He continued in this role when he transitioned to Oita University Hospital in 2021, where he currently leads efforts in diagnostic pathology.

🏅 Board Certifications and Licensure

Dr. Nishida holds multiple prestigious board certifications, including the Japanese Board Certification in Pathology, Autopsy, Cytology, and Molecular Pathology. He earned his National Board of Medicine license in 2009, showcasing his dedication to the field.

🌍 Professional Affiliations

Dr. Nishida is an active member of several professional organizations, both in Japan and internationally. He is involved with the Japanese Society of Pathology, Japanese Society of Clinical Cytology, Japan Dermatopathology Society, and the Bone and Soft Tissue Tumor Club of Japan. Additionally, he is a member of the United States and Canadian Academy of Pathology (USCAP) and the International Academy of Cytology.

Dr. Nishida’s contributions to the field of pathology, combined with his ongoing research and teaching, make him a distinguished figure in diagnostic pathology.

🚀 Conclusion

In summary, Dr. Haruto Nishida is a highly accomplished pathologist whose extensive expertise and dedication to diagnostic pathology have significantly contributed to the field. His career, marked by a progression of academic and clinical roles at Oita University, is underpinned by his strong educational background and numerous board certifications. As an active member of both national and international professional organizations, Dr. Nishida continues to impact the field through his research, teaching, and clinical work. His ongoing commitment to excellence in pathology makes him a respected leader in the medical community.

 

📊🔬NOTABLE PUBLICATION:

 

  • SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors
    Authors: Macagno, N., Kervarrec, T., Thanguturi, S., De la Fouchardière, A., Battistella, M.
    Journal: Modern Pathology
    Year: 2024

 

  • Recurrent Cardiac Tamponade Following Coronavirus Disease 2019 mRNA Vaccination: A Case Report
    Authors: Kaimori, R., Nishida, H., Yahiro, T., Iwami, T., Daa, T.
  • Journal: Cardiovascular Pathology
    Year: 2024

 

  • Lipid Droplet Detection in Histopathological Images Using Reinforcement Learning
    Authors: Harada, Y., Nishida, H., Matsuura, K.
    Journal: Biotechnology and Biotechnological Equipment
    Year: 2024

 

  • Right Atrial Cardiac Myxoma with Malignant Transformation to Undifferentiated Sarcoma: A Case Report
    Authors: Kaimori, R., Nishida, H., Oyama, Y., Kawamura, K., Daa, T.
    Journal: Cardiovascular Pathology
    Year: 2024

 

  • The Relationship Between Tumor Immunity and the cGAS–STING Pathway in Breast Cancer: An Immunohistochemical Study
    Authors: Nishida, H., Ohara, N., Kato, A., Kawamura, K., Daa, T.
    Journal: Experimental and Molecular Pathology
    Year: 2024